Bayer and Liveo Research Launch Innovative Blister Packaging with Significant Environmental Benefits
Bayer and Dewpoint Therapeutics Forge Landmark Heart Disease Licensing Deal
Bayer Joins Forces with Start-Up for Hormone Monitoring Breakthrough
Bayer and Orion Submit Darolutamide for Expanded Prostate Cancer Treatment in Europe
Bayer and MOMA Therapeutics Partner on Precision Oncology Small Molecule Program
FDA Accepts Bayer’s New Drug Application for Elinzanetant to Treat Menopause and its Symptoms
Positive 24-Month Data for BlueRock’s Bemdaneprocel in Parkinson’s Disease Trial
Bayer Seeks FDA Approval for Darolutamide in Metastatic Prostate Cancer
mHSPC: Darolutamide Plus ADT Shows Significant Reduction in Radiological Progression or Death
Safety Profile Highlighted in New Eyleaâ„¢ 8 mg Data from EURETINA 2024
Menopause Study Shows Promising Results for Elinzanetant in Treating Moderate to Severe Symptoms
Oncology Advances: Bayer to Present Extensive New Data from Its Oncology Portfolio at ESMO 2024